Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope- Study Presented at Heart Rhythm Society Supports Wound-Healing Benefits in Patients Receiving Cardiac Implantable Electronic Devices

SILVER SPRING, Md., May 19, 2023 — Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced that...

read more

Want to Stay up to Date on the Latest News?

Click below to join our mailing list.
External links are provided for informational purposes only.
Aziyo bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.